Quantum Blue®

Calprotectin


The Quantum Blue® Calprotectin lateral flow assay combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody to calprotectin), with full quantification by means of a small, telephone sized reading device. The Quantum Blue® Reader analyzes the signal intensity from the test and control line to give a quantitative value and is standardized with the BÜHLMANN fCAL® ELISA.

CRP


The Quantum Blue® C-Reactive Protein (CRP) lateral flow assay is designed for the quantitative determination of CRP in human serum in combination with the BÜHLMANN Quantum Blue ® Reader. Less than 50 µl serum is required to perform the lateral flow test for CRP. The intended use of Quantum Blue ® hsCRP is for the study of irritable bowel disease (IBD) related research.

MRP8/14


The Quantum Blue® sCAL lateral flow assay is designed for the quantitative determination of MRP8/14 in human serum in combination with the BÜHLMANN Quantum Blue® Reader. The MRP8/14 assays by BÜHLMANN allow for precise and sensitive measurement of this important marker for research related to inflammation.

BUHLMANN-Calprotectin-Ascities_Quantum-Blue

Calprotectin-Ascites


The measurement of calprotectin in ascitic fluid provides reliable and rapid results using the Quantum Blue® technology for the determination of calprotectin concentrations in human ascites in combination with the Quantum Blue® Reader.

Quantum Blue® Infliximab


The BÜHLMANN Quantum Blue® Infliximab is the first rapid test to measure infliximab in serum samples. The test is designed for the selective measurement of infliximab by a sandwich immunoassay in human serum samples in combination with the BÜHLMANN Quantum Blue® Reader.

Sign Up for BUHLMANN Updates!

Enter your email and stay on top of things,